← Leaderboards
Toshiyuki Yoneda
University Of Texas Hlth Sci Ctr San Ant
$2,044,829
Attributed
$2,044,829
Total exposure
3
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $354.1K · FY2005–07$500K$375K$250K$125K$0
'05
'06
'07
Funding mix
By agency
NIH$2,044,829 · 3
By mechanism
R01$1,863,315 · 2
P01$181,514 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Texas Hlth Sci Ctr San Ant
Same institution · by research overlap
- Gregory R Mundy$7,763,862
- Theresa A Guise$8,674,181
- G David Roodman$13,528,230
- Peter John Hart$4,421,670
- Andrew P Hinck$7,633,012
Others in their field
Top investigators on “Athymic Mouse”
- Thomas F Deuel · Beth Israel Deaconess Medical Center$7,283,721
- Ralph Weissleder · Massachusetts General Hospital$5,688,124
- Donald P McDonnell · Duke University$5,386,390
- Oliver W. Press · Fred Hutchinson Cancer Research Center$5,178,285
- Channing J Der · University Of North Carolina Chapel Hill$4,926,790
- Murray Korc · University Of California Irvine$4,764,672
Research focus
Athymic MouseNuclear Factor Kappa BetaMetastasisBreast NeoplasmsBone NeoplasmsPhysiologic Bone ResorptionReceptor ExpressionGrowth Factor ReceptorsFemaleHistopathologyInsulinlike Growth FactorAntisense Nucleic AcidDisease /Disorder ModelCell ProliferationNeutralizing AntibodyWestern BlottingsMonoclonal AntibodyProtein Quantitation /DetectionX RayOsteopontinAutocrineParacrineAngiogenesisCell Migration
Grant awards (13)
Osteopontin and Bone Metastasis in Breast Cancer$309,748
R01 · FY2007 · AR · contact PI
Osteopontin and Bone Metastasis in Breast Cancer$318,998
R01 · FY2006 · AR · contact PI
Osteopontin and Bone Metastasis in Breast Cancer$354,050
R01 · FY2005 · AR
Osteopontin and Bone Metastasis in Breast Cancer$354,050
R01 · FY2004 · AR
Osteopontin and Bone Metastasis in Breast Cancer$346,018
R01 · FY2003 · AR
Bone derived IGFs in bone metastasis of human breast cancer$0
P01 · FY2002 · CA
Bone derived IGFs in bone metastasis of human breast cancer$0
P01 · FY2002 · CA
Bone derived IGFs in bone metastasis of human breast cancer$0
P01 · FY2002 · CA
Bone derived IGFs in bone metastasis of human breast cancer$0
P01 · FY2002 · CA
Bone derived IGFs in bone metastasis of human breast cancer$0
P01 · FY2001 · CA
Bone derived IGFs in bone metastasis of human breast cancer$0
P01 · FY2001 · CA
Bone derived IGFs in bone metastasis of human breast cancer$181,514
P01 · FY2000 · CA
MOLECULAR MECHANISM OF C-SRC REGULATION IN OSTEOCLASTS$180,451
R01 · FY2000 · DK